The pharmacist will see you now: Pharmacist prescriptive authority and access to care

Shishir Shakya, Alicia Plemmons, Kihwan Bae and Edward Timmons

Contemporary Economic Policy, 2025, vol. 43, issue 1, 161-174

Abstract: In 2018, Idaho became the first state to grant broad prescriptive authority to pharmacists for select medications, such as rescue inhalers (a drug to prevent and treat asthmatic symptoms) and insulin pen needles (for people with diabetes). We analyze the impact of this reform on Medicare beneficiaries' access to these time‐sensitive treatments. Our findings reveal increased Medicare Part D claims, 30‐day fills, and 30‐day supplies of albuterol sulfate and insulin pen needles following expanded pharmacist authority. This translates to approximately three additional patients per pharmacist receiving timely care, potentially preventing costly alternatives such as emergency room visits.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1111/coep.12647

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bla:coecpo:v:43:y:2025:i:1:p:161-174

Ordering information: This journal article can be ordered from
https://ordering.onl ... 5-7287&ref=1465-7287

Access Statistics for this article

Contemporary Economic Policy is currently edited by Brad R. Humphreys

More articles in Contemporary Economic Policy from Western Economic Association International Contact information at EDIRC.
Bibliographic data for series maintained by Wiley Content Delivery ().